629 related articles for article (PubMed ID: 15958262)
1. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
[TBL] [Abstract][Full Text] [Related]
2. Characterization and subcellular localization of KCNQ1 with a heterozygous mutation in the C terminus.
Yamashita F; Horie M; Kubota T; Yoshida H; Yumoto Y; Kobori A; Ninomiya T; Kono Y; Haruna T; Tsuji K; Washizuka T; Takano M; Otani H; Sasayama S; Aizawa Y
J Mol Cell Cardiol; 2001 Feb; 33(2):197-207. PubMed ID: 11162126
[TBL] [Abstract][Full Text] [Related]
3. [HERG K+ channel, the target of anti-arrhythmias drugs].
Guan FY; Yang SJ
Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
[TBL] [Abstract][Full Text] [Related]
4. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
5. Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6.
Lu Y; Mahaut-Smith MP; Huang CL; Vandenberg JI
J Physiol; 2003 Aug; 551(Pt 1):253-62. PubMed ID: 12923204
[TBL] [Abstract][Full Text] [Related]
6. HERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.
Yang HT; Sun CF; Cui CC; Xue XL; Zhang AF; Li HB; Wang DQ; Shu J
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):822-7. PubMed ID: 19215240
[TBL] [Abstract][Full Text] [Related]
7. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
Ohno S; Toyoda F; Zankov DP; Yoshida H; Makiyama T; Tsuji K; Honda T; Obayashi K; Ueyama H; Shimizu W; Miyamoto Y; Kamakura S; Matsuura H; Kita T; Horie M
Hum Mutat; 2009 Apr; 30(4):557-63. PubMed ID: 19306396
[TBL] [Abstract][Full Text] [Related]
8. Clinical and electrophysiological characterization of a novel mutation (F193L) in the KCNQ1 gene associated with long QT syndrome.
Yamaguchi M; Shimizu M; Ino H; Terai H; Hayashi K; Mabuchi H; Hoshi N; Higashida H
Clin Sci (Lond); 2003 Apr; 104(4):377-82. PubMed ID: 12653681
[TBL] [Abstract][Full Text] [Related]
9. DHPLC analysis of potassium ion channel genes in congenital long QT syndrome.
Jongbloed R; Marcelis C; Velter C; Doevendans P; Geraedts J; Smeets H
Hum Mutat; 2002 Nov; 20(5):382-91. PubMed ID: 12402336
[TBL] [Abstract][Full Text] [Related]
10. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.
Wang L; Wible BA; Wan X; Ficker E
J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614
[TBL] [Abstract][Full Text] [Related]
11. A common antitussive drug, clobutinol, precipitates the long QT syndrome 2.
Bellocq C; Wilders R; Schott JJ; Louérat-Oriou B; Boisseau P; Le Marec H; Escande D; Baró I
Mol Pharmacol; 2004 Nov; 66(5):1093-102. PubMed ID: 15280442
[TBL] [Abstract][Full Text] [Related]
12. [Molecular genetics of the long QT syndrome: clinical aspects].
Sepp R; Csanády M
Orv Hetil; 1999 Nov; 140(47):2633-8. PubMed ID: 10613047
[TBL] [Abstract][Full Text] [Related]
13. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
[TBL] [Abstract][Full Text] [Related]
14. Functional effects of a KCNQ1 mutation associated with the long QT syndrome.
Boulet IR; Raes AL; Ottschytsch N; Snyders DJ
Cardiovasc Res; 2006 Jun; 70(3):466-74. PubMed ID: 16564513
[TBL] [Abstract][Full Text] [Related]
15. Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations.
Lupoglazoff JM; Denjoy I; Villain E; Fressart V; Simon F; Bozio A; Berthet M; Benammar N; Hainque B; Guicheney P
J Am Coll Cardiol; 2004 Mar; 43(5):826-30. PubMed ID: 14998624
[TBL] [Abstract][Full Text] [Related]
16. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene-without QT interval prolongation.
Yuill KH; Borg JJ; Ridley JM; Milnes JT; Witchel HJ; Paul AA; Kozlowski RZ; Hancox JC
Biochem Biophys Res Commun; 2004 May; 318(2):556-61. PubMed ID: 15120636
[TBL] [Abstract][Full Text] [Related]
18. A double-point mutation in the selectivity filter site of the KCNQ1 potassium channel results in a severe phenotype, LQT1, of long QT syndrome.
Ikrar T; Hanawa H; Watanabe H; Okada S; Aizawa Y; Ramadan MM; Komura S; Yamashita F; Chinushi M; Aizawa Y
J Cardiovasc Electrophysiol; 2008 May; 19(5):541-9. PubMed ID: 18266681
[TBL] [Abstract][Full Text] [Related]
19. A hydrophobicity-dependent motif responsible for surface expression of cardiac potassium channel.
Pan N; Sun J; Lv C; Li H; Ding J
Cell Signal; 2009 Feb; 21(2):349-55. PubMed ID: 19041715
[TBL] [Abstract][Full Text] [Related]
20. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]